Gilbert syndrome definition
Gilbert syndrome is defined as a common genetic disorder that affects the metabolism of bilirubin in the liver. It is an autosomal recessive condition that leads to mild to moderate unconjugated hyperbilirubinemia (increased levels of bilirubin in the blood), it is often presented as recurrent jaundice episodes.
Common factors such as fasting, febrile illness, hemolytic reactions, and menstruation can trigger high levels of bilirubin in the blood.
Gilbert syndrome is managed by
hepatologists and
gastroenterologists.
Gilbert syndrome meaning
The original name for this disease condition “La Cholemie Simple Familiale” was given by Gilbert, Castaigne, and Lereboullet in the early 1900, and it was described as an asymptomatic elevation of bilirubin. It was studied by several famous physicians including the Dutch biochemist Van den Bergh and the Danish physician Jens Einar Meulengracht. Many names were proposed for this condition including hereditary non-hemolytic bilirubinemia, familial non-hemolytic jaundice, and constitutional hepatic dysfunction. Today, Gilbert syndrome is the universally accepted name for this condition.
The prevalence of Gilbert syndrome is between 4% and 16 % but this rate can differ depending on an individual’s ethnic ancestry (cultural or ethnic origin) In America, the prevalence is estimated to be 2 % to 10% whereas in Japan and East Asia, it is estimated to be around 2%.
In India, the prevalence of Gilbert syndrome is about 20 %. In males’ differences in concentrations of sex steroid and higher bilirubin concentration account for the higher prevalence. Clinical manifestations present more often in early adolescence and are generally seen in men.
Mutations or changes in the UGT1A1 gene cause Gilbert syndrome. The UGT1A1 gene provides instructions to produce bilirubin uridine diphosphatase glucuronosyltransferase (bilirubin – UGT) enzyme which is found in liver cells. This enzyme removes bilirubin from the body.
A chemical reaction called glucuronidation is performed by the enzyme bilirubin UGT enzyme. During glucuronidation, the enzyme transfers glucuronic acid to unconjugated bilirubin which is then converted to conjugated bilirubin. This conjugated bilirubin dissolves in water and is removed from the body.
The most common genetic mutation that causes Gilbert syndrome (called UGT1A1*28) in many populations develops in an area near the UGT1A1 gene called as promoter region. This promoter region controls the production of the bilirubin UGT enzyme. The genetic mutation impairs enzyme production. In Asians, a gene mutation changes a single protein building block known as an amino acid. This type of mutation results in decreased enzyme function and is known as missense mutation.
Unconjugated bilirubin is not glucuronidated quickly as people with Gilbert syndrome have 30 % of normal bilirubin UGT enzyme function. As a result, unconjugated bilirubin accumulates in the body causing mild hyperbilirubinemia.
Not everyone with Gilbert syndrome develops hyperbilirubinemia, which indicates that other factors hinder the glucuronidation process and contribute to the condition. For instance, red blood cells may break down and release excess levels of bilirubin. Alternatively, the passage of bilirubin into the liver where it should be glucuronidated gets impaired.
Many patients with Gilbert syndrome may experience occasional or short-lived episodes of jaundice (yellowing of the whites of eyes and skin) due to the buildup of high levels of bilirubin. The yellowing due to jaundice is mild, as Gilbert syndrome causes a slight increase in bilirubin. Some people may experience other symptoms during episodes of jaundice such as:
Individuals with Gilbert syndrome often find that there are few triggers or risk factors that can bring jaundice episodes. Risk factors or triggers that can increase the risk of hyperbilirubinemia (increased levels of bilirubin in blood) include:
It is a benign, autosomal recessive inherited disorder that affects the metabolism of bilirubin. Individuals with Gilbert syndrome are at increased risk for the following:
There are no proven complications of Gilbert syndrome. It is not a risk for progressive liver disease or liver related mortality.
In the majority of cases, Gilbert syndrome is so mild that there are no symptoms. However, medical investigation is necessary as this condition is associated with symptoms similar to serious liver disease. Diagnosis of Gilbert syndrome includes the following:
Gilbert syndrome is correlated with an isolated unconjugated hyperbilirubinemia, with a serum total bilirubin of up to 4 mg/dL. This syndrome can be diagnosed by a blood test which measures levels of bilirubin in serum and liver function tests.
The liver releases enzymes in the blood when it gets damaged, at the same time protein levels begin to drop. Liver functionality can be estimated by measuring the levels of these enzymes and proteins. If liver function test results show high levels of bilirubin in the blood and the liver shows normal function, then a confirmed diagnosis of Gilbert syndrome can be made.
Genetic testing can be performed with assays of UGT1A1 activity and polymerase chain reaction (PCR). It is performed to identify gene polymorphism and can be considered in case of diagnostic uncertainty, especially when certain drugs may affect UGT1A1 activity.
Treatment is not required in individuals with Gilbert syndrome, as the condition is self-limiting (It resolves on its own within a few weeks). Management generally consists of reassuring patients and their families that this is a benign condition and does not require further testing and treatment.
Gilbert syndrome v/s Crigler Najjar
Gilbert syndrome and Crigler Najjar syndrome are both inherited disorders that affect the conjugation of bilirubin, but they have some key differences. The following are some of the parameters that differentiate Gilbert syndrome and Crigler Najjar syndrome:
Parameters | Gilbert syndrome | Crigler najjar syndrome |
---|---|---|
Definition | It is a common genetic disorder that affects the metabolism of bilirubin in the liver. It often leads to mild to moderate hyperbilirubinemia (increased bilirubin levels in blood). | It is a rare autosomal recessive inherited disorder which leads to non-hemolytic jaundice. |
Symptoms | It is asymptomatic and generally presented as recurrent episodes of jaundice. | Confusion, yellowing of skin, yellowing of whites of eyes (jaundice), vomiting, poor appetite. |
Causes | Mutations or changes in the UGT1A1 gene cause Gilbert syndrome. | It is caused by the absence or decreased level of UGT enzyme due to a genetic defect in bilirubin UDP glucuronosyltransferase family 1 polypeptide A1 gene. |
Treatment | Treatment is not required as this condition is self-limiting. | Primary treatment focuses on lowering the levels of unconjugated bilirubin through phototherapy and plasmapheresis. Liver transplantation is the only curative treatment for type 1 Crigler najjar syndrome. |
No, there is no specific treatment for Gilbert syndrome. Gilbert syndrome is a condition that is asymptomatic, and it is a self-limiting condition that does not require any treatment.
Yes, alcohol can increase the risk of developing Gilbert syndrome. Gilbert syndrome is an autosomal recessive condition characterized by hyperbilirubinemia (increased bilirubin). Excessive alcohol consumption increases bilirubin levels thereby increasing the risk.
Gilbert syndrome is a condition that lasts for a lifetime. It does not pose any threat to health nor cause any complications or damage to the liver.
Yes, Gilbert syndrome, or more precisely hyperbilirubinemia can result in weight loss. Studies on bilirubin induced transcriptome responses showed that it acts selectively via PPAR alpha (peroxisome proliferator-activated receptor) inducing transcription of genes. This gene transcription activates mitochondrial function to utilize fats for energy and reduces body weight.
Stress does not directly cause Gilbert syndrome, but it can trigger episodes of jaundice (jaundice being the primary symptom of Gilbert syndrome) in patients with Gilbert syndrome.
No, there is no cure or treatment for Gilbert syndrome. It is a lifelong condition that does not require any treatment as it is not life threatening and does not cause any damage to the liver nor lead to complications.
The diagnosis of Gilbert syndrome includes a blood test to measure the levels of serum bilirubin, a liver function test, and genetic testing. Enzymes are released into the blood when the liver gets damaged. At this time the levels of proteins produced by the liver begin to drop. By comparative measurement of levels of these enzymes and proteins, how well a liver is functioning can be estimated. A confirmed diagnosis of Gilbert syndrome can be made when there is a rise in serum bilirubin levels with normal liver function.
Individuals with Gilbert syndrome do not require treatment as this condition is self-limiting and is not life threatening. Management generally involves reassuring patients and their caretakers that this is a benign condition that does not require further testing.
Genetic testing of the UGT1A1 is performed to facilitate diagnosis of Gilbert syndrome. In this test, DNA is extracted from the blood sample of patient with unconjugated hyperbilirubinemia, and after amplification of polymerase chain reaction (PCR), the UGT1A1 gene is sequenced. The known pathogenic variants were identified after alignment with reference sequences and the variant spectrum was analyzed.
Gilbert syndrome is caused by the deficiency of the enzyme uridine diphosphate glucuronosyltransferase (UGT). This enzyme converts unconjugated bilirubin to conjugated bilirubin by transferring glucuronic acid to unconjugated bilirubin.
Yes, Gilbert syndrome is a disability. Many medical evidence demonstrates that it is a disability in which the hereditary enzyme results in serum bilirubin elevation. Veterans’ disability (VA) has been evaluated by analogy to the rating criteria of chronic liver disease.
Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Oops, there was an error sending your message. Please try again later. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Metro Pillar Number C1772, Beside Avasa Hotel, Hitech City Road, Near HITEC City Metro Station, Hyderabad, Telangana, India.
Mythri Nagar, Beside South India Shopping Mall, Hafeezpet, Madeenaguda, Hyderabad, Telangana, India.
040 4848 6868
Payment in advance for treatment at PACE Hospitals, Hyderabad, Telangana, India (Pay in INR ₹)
For Bank Transfer:-
Scan QR Code by Any Payment App (GPay, Paytm, Phonepe, BHIM, Bank Apps, Amazon, Airtel, Truecaller, Idea, Whatsapp etc).
Thank you for subscribing to PACE Hospitals' Newsletter. Stay updated with the latest health information.
Oops, there was an error. Please try again submitting your details.
Disclaimer
General information on healthcare issues is made available by PACE Hospitals through this website (www.pacehospital.com), as well as its other websites and branded social media pages. The text, videos, illustrations, photographs, quoted information, and other materials found on these websites (here by collectively referred to as "Content") are offered for informational purposes only and is neither exhaustive nor complete. Prior to forming a decision in regard to your health, consult your doctor or any another healthcare professional. PACE Hospitals does not have an obligation to update or modify the "Content" or to explain or resolve any inconsistencies therein.
The "Content" from the website of PACE Hospitals or from its branded social media pages might include any adult explicit "Content" which is deemed exclusively medical or health-related and not otherwise. Publishing material or making references to specific sources, such as to any particular therapies, goods, drugs, practises, doctors, nurses, other healthcare professionals, diagnoses or procedures is done purely for informational purposes and does not reflect any endorsement by PACE Hospitals as such.